Summary
Quantitative structure-activity relationships (QSARs) of different cardiotonic agents are presented. A critical analysis of all QSARs provides a very vivid picture of the mechanisms of varying cardiotonic agents. The cardiotonics can be broadly put into 2 categories: cardiac glycosides and nonglycoside cardiotonics, which include phosphodiesterase of type III (PDE III) inhibitors, sympathomimetic (adrenergic) stimulants, A1-selective adenosine antagonists, Ca2+ channel activators and vasopressin antagonists. For cardiac glycosides, QSARs reveal that the position of carbonyl oxygen in their lactone moiety and shifting of the lactone ring from its original position or its replacement by another group would be crucial for their activity. The carbonyl group or its isostere like CN is indicated to be the sole binding entity and the hydrogen bonding through this group is considered to be the most likely binding force. For nonglycoside cardiotonics that include PDE III inhibitors and A1-selective antagonists, a five-point model has been established for their activity, the salient features of which are: (1) the presence of a strong dipole, (2) an adjacent acidic proton, (3) a methyl-sized lipophilic space, (4) a relatively flat overall topography and (5) a basic or hydrogen-bond acceptor site opposite to the dipole. For Ca2+ channel activators, the importance of steric, electrostatic, lipophilic and hydrogen-bonding properties of molecules is indicated, while for vasopressin antagonists the lipophilic and electronic properties are suggested to be the most important.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
W.C. Bowman and M.J. Rand: Textbook of pharmacology, 2nd ed., Blackwell Scientific Publications, London 1980, Ch. 22 and 23.
R.E. Thomas: In: M.E. Wolf (ed.): Burger’s medicinal chemistry, 4th ed., John Wiley and Sons, New York 1981, Part III, p. 47.
B.F. Hoffman and J.T. Bigger Jr.: In: A.G. Gilman, L.S. Goodman, T.W. Rall and F. Murad (eds.): Goodman and Gilman’s the pharmaceutical basis of therapeutics, 7th ed., Macmillan Publishing Company, New York 1985, p. 716;
J.T. Bigger, Jr. and B.F. Hoffman: In: (a), p. 748;
P. Rudd and T.F. Blaske: In: (a), p. 784;
P. Needleman, P.B. Corr and E.M. Johnson, Jr.: In: (a), p. 806;
M.S. Brown and J.L. Goldstein: In: (a), p. 827.
D.G. Allen and J.R. Blinks: Nature (London) 273, 509 (1978).
J.W. Deitmer and D.J. Ellis: J. Physiol. (London) 284, 241 (1978).
D.C. Gadsby and P.F. Cranefield: Proc. Natl. Acad. Sci. USA 76, 1783 (1979).
C.O. Lee and M. Dagostino: Biophys. J. 40, 185 (1982).
D.A. Eisner, W.J. Lederer and R.D. Vaughan-Jones: J. Physiol. (London) 335, 723 (1983).
J.R. Blinks, W.G. Wier, J.P. Morgan and P. Hess: In: H. Xoshita, Y. Hagiwara and S. Ebashi (eds.): Advances in pharmacology and therapeutics II, Vol.3: Cardio-renal and cell pharmacology, Pergamon Press, Oxford 1982, p. 205.
D. Noble: Cardiovasc. Res. 14, 495 (1980).
A. Gervais, L.K. Lane, B.N. Annes, G.E. Lindermayer and A. Schwartz: Circ. Res. 40, 8 (1977).
R. Weingart: In: Cardiac glycosides, Part 1: Handbook of experimental pharmacology, Springer-Verlag, Berlin 1981, Vol. 56/1, p. 221.
E. Marbin and R.W. Tsien: J. Physiol. (London) 329, 589 (1982).
T.J. Hougen and T.W. Smith: Circ. Res. 42, 856 (1978).
R.E. Weishaar, M. Quade, D. Boyd, J. Schenden and H.R. Kaplan: Drug Dev. Res. 3, 517 (1983).
S.F. Campbell, N.J. Cussans, J.C. Danilewicz, A.G. Evans, A.L. Ham, A.A. Jaxa-Chamiec, D.A. Robers and J.K. Stubbs: Roy. Soc. Chem. (Spl. Publ.), No. 54, 47 (1984).
R.E. Weishaar, M.H. Cain and J.A. Bristol: J. Med. Chem. 28, 537 (1985).
A.A. Alousi, L.H. Watton, G.Y. Leshur and A.E. Farah: Roy. Soc. Chem. (Spl. Publ.) No. 50, 65 (1984).
T. Kariya, L.T. Willey and R.C. Dage: J. Cardiovasc. Pharmacol. 4, 50 (1982).
T. Kariya, L.T. Willey and R.C. Dage: J. Cardiovasc. Pharmacol. 6, 50 (1984).
R.E. Weishaar, M. Quade, J.A. Schenden, D.K. Boyd and D.B. Evans: Pharmacologist 25, 551 (1983).
R.E. Weishaar, M. Quade, J.A. Schenden, D.K. Boyd and D.B. Evans: Proc. Fed. Am. Soc. Exp. Biol. 44, 1792 (1985).
G.A. Robinson, R.W. Butcher and E.W. Sutherland: Cyclic AMP, Academic Press, New York 1971.
E.W. Sutherland, G.A. Robinson and R.W. Butcher: Circulation 37, 279 (1968).
S. Swillens and J.E. Dumont: Life Sci. 27, 1013 (1980).
G.S. Francis: Am. Heart J. 118, 642 (1989).
W.H. Newman, S.J. Grossman, M.B. Franskis and J.G. Webb: J. Mol. Cell. Cardiol. 16, 577 (1984).
L. Belardinelli, A. West, R. Crampton and R.M. Berne: In: R.M. Berne, T.W. Rall and R. Rubio (eds.): Regulatory function of adenosine, Nihoff, Boston 1983.
M. Endoh, M. Maruyama and N. Taira: In: J.W. Daly, Y. Kuroda, J.W. Phillis, and H. Schmizu, VI (eds.): Physiology and pharmacology of adenosine derivatives, Raven Press, New York 1983, p. 127.
A. Pelleg, T. Mitsouka and E.L. Michelson: J. Pharmacol. Exp. Ther. 242, 791 (1987).
L. Belardinelli and G. Isenberg: Am. J. Physiol. 244, H 734 (1983).
M. Bohm, R. Bruckner, I. Hackabarth, B. Haubitz, R. Linhart, W. Meyer, B. Schmidt, W. Schmidz and H. Scholz: J. Pharmacol. Exp. Ther. 230, 483(1984).
E. Cerbai, U. Klockner and G. Isenberg: Am. J. Physiol. 255, H 872 (1988).
M. Prostan and V.M. Varagic: Arch. Int. Pharmacodyn. 294, 137 (1988).
G. Jochem and H. Nawrathm: Experientia 39, 1347 (1983).
S. Visentin, S.N. Wu and L. Belardinelli: Am. J. Physiol. 258, H1070 (1990).
W.F. Lubbe, T. Podzuweit and L.H. Opie: J. Am. Cell. Cardiol. 19, 1622 (1992).
M. Packer: Am. Coll. Cardiol. 12, 1299 (1988);
M. Packer, J.R. Carver, R.J. RodeSatya P. Guptaheffer, R.J. Ivanhoe, R. Dibianco, S.M. Zeldis, G.H. Hendrix, W.J. Bommer, D. Elkayam, M.L. Kukin et al.: N. Engl. J. Med. 325, 1468 (1991).
D.J. Triggle: In: J.C. Emmett (ed.): Comprehensive medicinal chemistry, Vol. 3, Pergamon Press, Oxford 1990, p. 1047.
M. Manning and W.H. Sawyer: J. Recept. Res. 13, 195 (1993).
L.B. Kinter, W.F. Huffman and F.L. Stassen: Am. J. Physiol. 254, F165 (1988).
F.A. Laszlo Jr. and D. De Wied: Pharmacol. Rev. 43, 73 (1991).
J.D. Albright and P.S. Chan: Current. Pharm. Des. 3, 615 (1997).
H. Kubinyi: QSAR: Hansch analysis and related approaches, VCH Publishers, Weinheim- New York 1993.
S.P. Gupta, P. Singh and M.C. Bindal: Chem. Rev. 83, 633 (1983).
S.P. Gupta: Chem. Rev. 87, 1183 (1987).
S.P. Gupta: Chem. Rev. 89, 1765 (1989).
S.P. Gupta: Chem. Rev. 91, 1109 (1991).
S.P. Gupta: Chem. Rev. 94, 1507 (1994).
S.P. Gupta: Prog. Drug. Res. 45, 67 (1995).
S.P. Gupta: Current Pharm. Des. 4, 455 (1998).
S.P. Gupta: Prog. Drug Res. 53, 53 (1999).
R. Garg, S.P. Gupta, H. Gao, S.B. Mekapati, A.K. Debnath and C. Hansch: Chem. Rev. 99, 3525 (1999).
D.S. Fullerton, K. Yoshioka, D.C. Rohrer, A.H.L. From and K. Ahmed: Science 205, 917 (1979).
D.C. Rohrer, D.S. Fullerton, K. Yoshioka, A.H.L. From and K. Ahmed: ACS Symp. Ser. No.112, 259 (1979).
S.P. Gupta and A. Paleti: Personal communication.
A. Cerri, F. Serra, P. Ferrari, E. Folpini, G. Padoani and P. Melloni: J. Med. Chem. 40, 3484 (1997).
M. Bohl, K. Ponsold and G. Reck: J. Steroid Biochem. 21, 373 (1984).
K.R.H. Repke, F. Dittrich, P. Berlin and H.H. Portius: Ann. N.Y. Acad. Sci. 242, 737 (1974).
C.S. Davies and R.P. Halliday: In: A. Burger (ed.): Medicinal chemistry, 3rd Ed., Vol. 5, Part 2, John-Wiley, New York 1970, p. 1065.
T.W. Guntert and H.H. Linde: Experientia 33, 697 (1977).
R. Thomas, J. Boutagy and A. Gelbart: J. Pharm. Sci. 63, 1649 (1974).
C.K. Chiu and T.R. Watson: J. Med. Chem. 28, 509 (1985).
R. Thomas, P. Gray and J. Andrews: Adv. Drug. Res. 19, 311 (1990).
K. Repke: Internist 7, 418 (1966).
K. Repke and H.J. Portius: Arzneim.-Forsch. 14, 1073 (1964).
W. Schonfeld, J. Weiland, C. Lindig, M. Masnyk, M.M. Kabat, A. Kurek, J. Wicha and K.R.H. Repke: Naunyn Schmiedebergs Arch. Pharmacol. 329, 414 (1985).
K.K. Chen and R.C. Elderfield: J. Pharmacol. Exp. Ther. 70, 338 (1940).
W.A. Jacobs: J. Biol. Chem. 88, 519 (1930).
R. Thomas, J. Boutagy and A. Gelbart: J. Pharmacol. Exp. Ther. 191, 219 (1974).
D.S. Fullerton, K. Ahmed, A.H.L. From, R.H. McParland, D.C. Rohrer and J.F. Griffin: In: A.S.V. Burgen, G.C.K. Roberts and M.S. Tute (eds.): Molecular graphics and drug design, Elsevier, Amsterdam 1986, p. 257.
B. Forbush III.: Curt Top. Membr. Transp. 19, 167 (1983).
M.P. Goeldner, C.G. Hirth, B. Rossi, G. Ponzio and M. Lazdunski: Biochemistry 22, 4685 (1983).
B. Rossi, G. Ponzio and M. Lazdunski: EMBO J. 1, 859 (1982).
B. Rossi, G. Ponzio, M. Lazdunski, M. Goeldner and C. Hirth: Curr. Top. Membr. Transp. 19, 271 (1983).
C. Hall and A. Ruoho: Proc. Natl. Acad. Sci. USA 77, 4529 (1980).
P.L. Jorgensen, E. Skriver, H. Hebert and A.B. Maunsbach: Ann. N.Y. Acad. Sci. 402, 207 (1982).
E.T. Wallick, T.L. Kirley and A. Schwartz: In: E. Erdman, K. Greeff and J.C. Skou (eds.): Cardiac glycosides 1785–1985, Steinkoff Verlag, Darmstadt 1986, p. 27.
G.E. Shull, A. Schwartz and J.B. Lingrel: Nature (London) 316, 691 (1985).
L. Quadri, A. Cerri, P. Ferrari, E. Folpini, M. Mabilia and P. Melloni: J. Med. Chem. 39, 3385 (1996).
M.J.S. Dewar and K.M. Dieter: J. Am. Chem. Soc. 108, 8075 (1986).
K. Repke and L.T. Samuels: Biochemistry 3 689 (1964).
A. Yoda, S. Yoda and A.M. Sarrif: Mol. Pharmacol. 9, 766 (1973).
A. Yoda: Ann. N.Y. Acad. Sci. 242, 598 (1974).
A. Yoda and S. Yoda: Mol. Pharmacol. 11, 653 (1975).
A. Yoda and S. Yoda: Mol. Pharmacol. 13, 352 (1977).
B.K. Naaido, T.R. Witty, W.A. Remers and H.R. Besch Jr.: J. Pharm. Sci. 63, 1391 (1974).
N. Shirai, J. Sakakibara, T. Kaiya, S. Kobayashi, Y. Hotta and K. Takeya: J. Med. Chem. 26, 851 (1983).
A. De Pover and T. Godfraind: Naunyn Schmiedebergs Arch. Pharmacol. 321, 135 (1982).
L. Brown, B. Lorenz and R.E. Thomas: Biochem. Pharmacol. 32, 2767 (1983).
A.E. Farah and A.A. Alousi: Life Sci. 22, 1139 (1978).
A.A. Alousi, J.M. Carter, M.J. Montenaro, D.J. Fort and R.J. Ferrari: J. Cardivasc. Pharmacol. 5, 792 (1983).
A. Ward, R.N. Brogdein, R.C. Heel, T.M. Speight and G.S. Avery: Drug 26, 468 (1983).
R.E. Weishaar, S.D. Burrows, D.C. Koybylarz, M.M. Quade and D.B. Evans: Biochem. Pharmacol. 35, 787 (1986).
M. Ito, T. Tanaka, M. Saitoh, H. Msuoka, T. Nahano and H. Hidaka: Biochem. Pharmacol. 37, 2041 (1988).
I. Sirkar, L.D. Bradley, G. Bobowsky, J.A. Bristol and D.B. Evan: J. Med. Chem. 28, 1405 (1985).
A.A. Hagedorn III, P.W. Erhardt, W.C. Lumma Jr., R.A. Wohl, R.E. Cantor, Y.L. Chou, W.R. Ingebresten, D. Pang, C.A. Pease and J. Wiggins: J. Med. Chem. 30, 1342 (1987).
H.W. Moos, C.C. Humblet, I. Sircar, C. Rithner, R.E. Weishaar, J.A. Bristol and A.T. McPhail: J. Med. Chem. 30, 1963 (1987).
P.W. Erhardt, A.A. Hagedorn III and M. Sabio: Mol. Pharmacol. 33, 1 (1987).
P.W. Erhardt and Y. Chou: Life Sci. 49, 553 (1991).
R. Boggia, M. Forina, P. Fossa and L. Mosti: Quant. Struct.-Act. Relat. 16, 201 (1997).
M. Forina, R. Boggia, L. Mosti and P. Fossa: Farmaco 52, 411 (1997).
V. Cody, A. Wojtczak, F.B. Davis and S.D. Blass: J. Med. Chem. 38, 1990 (1995).
H. Okushima, A. Narimatsu and R. Furuya: JP Kokai 8 015, 8 016 (1983);
H. Okushima, A. Narimatsu and I. Shimooda: JP Kokai 140 016 (1983).
H. Okushima, A. Narimatsu, M. Kobayashi, R. Furuya, K. Tsuda and Y. Kitada: J. Med. Chem. 30, 1157 (1987).
W. Diederen and R. Kadatz: Arzneim.-Forsch. 31, 141 (1981).
R.A. Schnettler, R.C. Dage and J.M. Grisar: J. Med. Chem. 25, 1477 (1982).
J.A. Bristol, I. Sirkar, W.H. Moos, D.B. Evans and R.E. Weishaar: J. Med. Chem. 27, 1099 (1984).
P.W. Erhardt: J. Med. Chem. 30, 231 (1987).
D. El Allaf, V. D’Orio and J. Calier: Arch. Int. Physio. Biochim. 92, 10 (1985).
D. Barraclough, R. Firmin, R. Iyer, W.R. King, J.C. Lindon, M.S. Nobbs, S. Smith, C.J. Wharton and J.M. Williams: J. Chem. Soc. Perkin Trans. 2,1839 (1988).
D.W. Robertson, E.E. Beedle, J.H. Krushinski, G. Don Pollock, H. Wilson, V. Wyss and J.S. Hayes: J. Med. Chem. 28, 717 (1985).
D.W. Robertson and J.S. Hayes: Drugs Future 10, 295 (1985).
G. Allan, D. Cambridge, M.J. Follenfant, D. Stone and M.V. Whiting: Br. J. Pharmacol. 93, 387 (1988).
P. Barraclough, J.W. Black, D. Cambridge, D. Collard, D. Firmin, V.P. Gerskowitch, R.C. Glen, H. Giles, A.P. Hill, R.A.D. Hull et al.: J. Med. Chem. 33, 2231 (1990).
A.A. Alousi, A.E. Farah, G.Y. Lesher and C.J. Opalka: Circ. Res. 45, 666 (1979).
I. Sirkar, R.E. Weishaar, D. Kobylarz, W.H. Moos and J.A. Bristol: J. Med. Chem. 30, 1955 (1987).
R.E. Weishaar, M.M. Quade, J.A. Schenden and D.B. Evans: J. Cyclic Nucleotide Protein Phosphor. Res. 10, 551 (1985).
R.E. Weishaar, M. Quade, J.A. Schenden, D.K. Boyd and D.B. Evans: Eur. J. Pharmacol. 119, 205 (1985).
D.B. Evans, R.E. Potoczak, R.P. Steffen, W.E. Burmeister, R.W. McNish, J.A. Schenden and H.R. Kaplan: Drug Dev. Res. 9, 143 (1986).
S.A. Harrison, D.H. Reifsnyder, B. Gallis, G.G. Cadd and J.A. Beavo: Mol. Pharmacol. 29, 506 (1986).
K.A. Walker, M.R. Boots, J.F. Stubbins, M.E. Rogers and C.W. Davis: J. Med. Chem. 26, 174 (1983).
S.P. Gupta, C. Garg and J.K. Gupta: Res. Commun. Chem. Pathol. Pharmacol. 61, 265 (1988).
Y.S. Prabhakar, A. Handa and S.P. Gupta: J. Pharmacobio-Dyn. 7, 366 (1984).
R.A. Glenon, M.E. Rogers, J.D. Smith, M.K. El-Said and J.L. Egle: J. Med. Chem. 24, 658 (1981).
A.M. Lands, T.G. Brown Jr.: In: A. Burger (ed.): Drugs affecting the peripheral nervous system, Vol. 1, Marcel Dekker, New York 1976, p. 399.
D.J. Triggle, in ref. 60, p.1235.
D. Carlstrom, R. Bergin and G. Falkenberg: Quart. Rev. Biophys. 6, 257 (1973).
P.N. Patil, J.B. Lapidiu and A. Tye: J. Pharm. Sci. 59, 1205 (1970).
P. Pratesi: International symposium on pharmaceutical chemistry, Florence, 1962, Butterworths, London 1963, p. 435.
P. Pratesi and E. Grana: Adv. Drug Res. 2, 127 (1965).
P. Pratesi, L. Villa and E. Grana: Farmaco 21, 409 (1966).
P. Pratesi, L. Villa and E. Grana: Farmaco 30, 315 (1975).
R.E. Tessel, J.E. Wooda, R.E. Counsell and G.P. Basmadjian: J. Pharmacol. Exp. Ther. 192, 319 (1975).
P. Dorigo and I. Maragno: Br. J. Pharmacol. 32, 623 (1986).
C.Q. Earl, J. Linden and W.B. Weglicki: J. Cardiovasc. Pharmacol. 8, 864 (1986).
W.J. Parson, V. Ramkumar and G.L. Stiles: Mol. Pharmacol. 33, 441 (1988).
P. Dorigo, R.M. Gaion and I. Maragno: Cardiovasc. Drug Ther. 4/2, 509 (1990).
M. Ungerer, M. Bohm, R.H.G. Schwinger and E. Erdman: Naunyn Schmiedebergs Arch. Pharmacol. 341, 577 (1990).
L. Mosti, G. Menozzi, P. Schenone, P. Dorigo, R.M. Gaion, F. Benetollo and G. Bombieri: Eur. J. Med. Chem. 24, 517 (1989).
L. Mosti, G. Menozzi, P. Schenone, P. Dorigo, R.M. Gaion and P. Belluco: Farmaco 47, 427 (1992).
L. Mosti, P. Schenone, M. Iester, P. Dorigo, R.M. Gaion and D. Fraccarollo: Eur. J. Med. Chem. 28, 853 (1993).
P. Dorigo, R.M. Gaion, P. Belluco, P.A. Borea, L. Guerra, L. Mosti, M. Floreani and F. Carpendo: Gen. Pharmacol. 23, 535 (1992).
P. Dorigo, R.M. Gaion, P. Belluco, D. Fraccarollo, I. Maragno, G. Bombieri, F. Benetollo and F. Orisini: J. Med. Chem. 36, 2475 (1993).
P. Dorigo, D. Fraccarollo, G. Santostasi, R.M. Gaion, I. Maragno, M. Floreani, F. Carpendo, M. Iester, L. Mosti and P. Schenone: Farmaco 49, 19 (1994).
F. Orsini, F. Benetollo, G. Bombieri and L. Mosti: Eur. J. Med. Chem. 25, 425 (1990).
F. Orsini, F. Benetollo, G. Bombieri and L. Mosti: Eur. J. Med. Chem. 28, 637 (1993).
P. Dorigo, D. Fraccarollo, G. Santostasi, I. Maragno, M. Floreani, P.A. Borea, L. Mosti, L. Sansebastino, P. Fossa, E Orsini et al.: J. Med. Chem. 39, 3671 (1996).
K.A. Jacobson, S. Barone, U. Kammula and G.L. Stiles: J. Med. Chem. 32, 1043 (1989).
B.C. Sharma, P. Singh, T.N. Ojha and S. Tiwari: Drug Des. Discov. 12, 169 (1994).
K.A. Jacobson, L. Kiriasis, S. Barone, B.J. Bradbury U. Kammula, J.M. Campagne, S. Secunda, J.W. Daly, J.L. Neumeyer and W. Pfeiderer: J. Med. Chem. 32, 1873 (1989).
K.A. Jacobson, C. Gallo-Rodrigsez, N. Melman, B. Fischer, M. Mailard, A. Van Bergen, P.J. Van Galen and K. Yishai: J. Med. Chem. 36, 1333 (1993).
T.N. Ojha, S. Tiwari, R.C. Sharma and P. Singh: Indian J. Chem. 34B, 452 (1995).
R.A. Janis, P. Silver and D.J. Triggle: Adv. Drug Res. 16, 309 (1987).
K. McKechnie, P.G. Killingback, I. Naya, S.E. O’Connor, G.W. Smith, D.W. Wattam, E. Wells, Y.M. Whitehead and G.E. Williams: Br. J. Pharmacol. 98, 673P (1989).
A.J.G. Baxter, J. Dixon, F. Ince, C.N. Manners and S.J. Teague: J. Med. Chem. 36, 2739 (1993).
A. Verloop, W. Hoogenstraaten and J. Tipker: In: E.J. Ariens (ed.): Drug design, Vol. VII, Academic Press, New York 1976, p. 165.
A.M. Davis, N.P. Gensmantel, E. Johansson and D.P. Marriot: J. Med. Chem. 37, 963 (1994).
D.J. Triggle, D.A. Langs and R.A. Janis: Med. Res. Rev. 9, 123 (1989).
R. Fossheim, K. Svarteng, A. Mostad, C. Romming, E. Shefter and D.J. Triggle: J. Med. Chem. 25, 126 (1982).
R. Fossheim, A. Joslyn, A.J. Solo, E. Luchowski, A. Rutledge and D.J. Triggle: J. Med. Chem. 31, 300 (1988).
D.A. Langs, Y.W. Kwon, P.D. Strong and D.J. Triggle: J. Comput-Aided Mol. Des. 5, 95 (1991).
R. Fossheim: Acta Chem. Scand. B41, 581 (1987).
H.-D. Holtje and S. Marrer: J. Comput-Aided Mol. Des. 1, 23 (1987).
S.C. Mah and K.G. Hofbauer: J. Pharmacol. Exp. Ther. 245, 1028 (1988).
W.F. Huffman, C. Albrightson-Winslow, B. Brickson, H.G. Bryan, N. Caldwell, G. Dytko, D.S. Eggleston, L.B. Kinter, M.L. Moore, K.A. Newlander et al.: J. Med. Chem. 32, 880 (1989).
C. Serradeil-Le Gal., J. Wagnon, C. Garcia, C. Lacour, P. Guiraudou, B. Christople, G. Vil-lanova, D. Nistato, J.P. Maffrand, G. Le Furr et al: J. Clin. Invest. 92, 224 (1993).
H. Ogawa, Y. Yamamura, H. Miyamato, K. Kondo, H. Yamishita, K. Nakaya, T. Chihara, T. Mori, M. Tominaga and Y. Yabuuchi: J. Med. Chem. 36, 2011 (1993).
H. Ogawa, H. Yamashita, K. Kondo, Y. Yamamura, H. Miyamoto, K. Kan, K. Kitano, M. Tanaka, K. Nakaya, S. Nakamura et al.: J. Med. Chem. 39, 3547 (1996).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Basel AG
About this chapter
Cite this chapter
Gupta, S.P. (2000). Quantitative structure - activity relationships of cardiotonic agents. In: Jucker, E. (eds) Progress in Drug Research. Progress in Drug Research, vol 55. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8385-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8385-6_7
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9544-6
Online ISBN: 978-3-0348-8385-6
eBook Packages: Springer Book Archive